Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Serina Therapeutics, Inc. is a clinical-stage biotechnology company developing proprietary polymer-based drug delivery technologies, primarily its POZ platform, to improve the efficacy and safety of therapeutics. The company focuses on CNS disorders, notably Parkinson’s disease, with drug candidates designed for continuous delivery of dopamine agonists via subcutaneous injection. Serina’s platform enables enhanced drug loading, controlled release, and reduced immunogenicity, targeting pharmaceutical developers and patients through internal development and partnerships.
This description was generated via AI from an annual report. Updated about 1 year ago.